Nurjana Bachman
About Nurjana Bachman
Nurjana Bachman serves as the Senior Vice President of Corporate Development and Strategy at ROME Therapeutics, where she has worked since 2022. With extensive experience in oncology diagnostics and therapeutics, she has held various leadership roles in notable organizations, including Foundation Medicine and Boston Children's Hospital.
Current Role at ROME Therapeutics
Nurjana Bachman serves as the Senior Vice President of Corporate Development and Strategy at ROME Therapeutics. She has held this position since 2022, contributing to the company's strategic direction and corporate development initiatives. Her role involves overseeing partnerships and collaborations that align with ROME Therapeutics' mission in the biotechnology sector.
Previous Experience at Foundation Medicine
Before joining ROME Therapeutics, Nurjana Bachman worked at Foundation Medicine in various roles from 2016 to 2022. She began as Alliance Director, then progressed to Senior Director of Alliance Management, and later served as Vice President of Biopharma and Corporate Alliances. During her tenure, she managed partnerships that resulted in over 50 companion diagnostic approvals and commercial launches in the US and Japan.
Educational Background
Nurjana Bachman obtained her Bachelor of Arts degree in Biology from Swarthmore College, where she studied from 1992 to 1996. She furthered her education at The Johns Hopkins University School of Medicine, earning a PhD in Molecular Biology and Genetics from 1998 to 2004. Her academic background provides a strong foundation for her work in oncology diagnostics and therapeutics.
Experience in Healthcare and Biotech
Nurjana Bachman has extensive experience in the healthcare and biotechnology sectors. She worked at Boston Children's Hospital as Licensing Manager and later as Associate Director of Strategic Initiatives and Business Development from 2005 to 2013. Additionally, she served as a consultant at New England Biolabs in 2004 and completed a summer internship at Merck from 1992 to 1993.
Expertise in Oncology and Team Leadership
Nurjana Bachman possesses deep international expertise in oncology diagnostics and therapeutics. She has a proven track record of achieving first-in-class therapeutic approvals through strategic partnerships. Her leadership skills are evident in her ability to grow teams and navigate organizational change, fostering a collaborative and positive culture within her teams.